CA
GOSS icon

Cliff Asness’s Gossamer Bio GOSS Stock Holding History

Cliff Asness’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
15,629,993
+5,503,096
+54% +$1.54M ﹤0.01% 2458
2026
Q1 		$3.33M Buy
10,126,897
+9,007,657
+805% +$14.2M ﹤0.01% 2015
2025
Q4 		$3.47M Buy
1,119,240
+472,625
+73% +$1.35M ﹤0.01% 1791
2025
Q3 		$1.7M Buy
+646,615
New +$1.43M ﹤0.01% 2083
2023
Q1 		– Sell
-14,473
Closed -$31.4K – 2202
2022
Q4 		$31.4K Buy
+14,473
New +$119K ﹤0.01% 2176

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cliff Asness's GOSS Position: Q2 2026 in Review

Cliff Asness increased its Gossamer Bio (GOSS) stake by 54% in Q2 2026, buying an estimated $1.54M and bringing the position to 15,629,993 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Cliff Asness first reported a position in GOSS in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.47M in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Cliff Asness held 15,629,993 shares of Gossamer Bio worth $2.57M as of Q2 2026.
  • Cliff Asness bought 5,503,096 Gossamer Bio shares in Q2 2026, an estimated $1.54M.
  • Gossamer Bio made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2458 holding.
  • Cliff Asness first reported a position in Gossamer Bio in Q4 2022 and has held it in 5 quarters since.
  • Cliff Asness's Gossamer Bio position peaked at $3.47M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.